Ethan Korngold: I’m Excited by The New CREST-2 Trial Data Presented at SVIN2025, VEITH2025 and Published in NEJM
Ethan Korngold, Chief Medical Officer and DVP of Medical Affairs for the Abbott Vascular Business Unit, shared on LinkedIn:
”I’m excited by the new CREST-2 trial data presented at SVIN2025, VEITH2025 and published in NEJM adding an important chapter to understanding stroke prevention in patients with high-grade asymptomatic carotid stenosis.
In the stenting trial, carotid artery stenting (CAS) added to intensive medical therapy was associated with 2.8% stroke and death out to 4-years vs 6.0% for medical therapy.
The absolute difference of 3.2% favoring CAS was significant.
We are proud of the role our market leading carotid technologies including Xact and Emboshield NAV6, have in advancing research in stroke prevention.
These results will encourage the field to re-examine long-held assumptions about asymptomatic disease management.
As new evidence emerges, our responsibility is to interpret it carefully, understand where it applies, and continue refining strategies that support long-term patient outcomes.
My gratitude to the CREST-2 investigators for their commitment to a rigorous comparative study.
Read the abstract in NEJM.
Stay updated with Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation